[Spin on]
[Spin off]
[Reset]
[High quality]
[Low quality]
[White background]
[Black background]
|
[Spin on]
[Spin off]
[Reset]
[High quality]
[Low quality]
[White background]
[Black background]
|
PDB | 8vy4 Engineering a tumor-selective prodrug T-cell engager bispecific antibody for safer immunotherapy. |
Resolution | 1.7 Å |
Binding residue (original residue number in PDB) | Y30 Y34 Y93 T95 T96 Y99 |
Binding residue (residue number reindexed from 1) | Y29 Y33 Y92 T94 T95 Y98 |
|